A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells. [electronic resource]
Producer: 20070816Description: 4656-67 p. digitalISSN:- 0950-9232
- Antineoplastic Agents, Hormonal -- therapeutic use
- Apoptosis
- Apoptosis Regulatory Proteins -- metabolism
- Breast Neoplasms -- drug therapy
- Cell Line, Tumor
- Cyclins -- metabolism
- DNA-Binding Proteins
- Drug Resistance, Neoplasm -- genetics
- Estradiol -- pharmacology
- Estrogen Antagonists -- therapeutic use
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Intracellular Signaling Peptides and Proteins -- genetics
- Nuclear Proteins -- genetics
- Tamoxifen -- analogs & derivatives
- Tumor Necrosis Factor alpha-Induced Protein 3
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.